News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
266 Results
Type
Article (14)
Company Profile (1)
Press Release (251)
Section
Business (102)
Deals (11)
Drug Development (51)
FDA (6)
News (160)
Policy (7)
Tag
Alliances (21)
Approvals (5)
Biotechnology (1)
Cancer (15)
Clinical research (47)
Collaboration (1)
Data (4)
Earnings (54)
Events (44)
Executive appointments (1)
FDA (8)
Funding (1)
GLP-1 (1)
Government (2)
Healthcare (5)
Infectious disease (1)
IPO (3)
Lung cancer (12)
Manufacturing (1)
Mergers & acquisitions (9)
NextGen: Class of 2026 (9)
Patient recruitment (1)
People (32)
Phase 1 (5)
Phase 2 (20)
Phase 3 (23)
Pipeline (8)
Postmarket research (3)
Preclinical (5)
Regulatory (9)
RSV (1)
Startups (2)
Vaccines (3)
Date
Last 30 days (2)
Last 365 days (37)
2026 (3)
2025 (38)
2024 (33)
2023 (10)
2022 (21)
2021 (20)
2020 (5)
2019 (6)
2018 (9)
2017 (24)
2016 (24)
2015 (40)
2014 (16)
2013 (4)
2012 (6)
2011 (4)
2010 (1)
Location
Asia (10)
Australia (1)
California (5)
China (2)
Europe (22)
Japan (2)
Kentucky (1)
Massachusetts (1)
Nevada (1)
New York (38)
Northern California (2)
Pennsylvania (1)
Southern California (2)
United States (46)
266 Results for "nuvation bio.rss".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Nuvation Bio to Present at the 44th Annual J.P. Morgan Healthcare Conference
January 7, 2026
·
1 min read
Press Releases
Nuvation Bio to Participate in Upcoming December 2025 Investor Conferences
November 27, 2025
·
1 min read
Lung cancer
Nuvation Scores First FDA Nod With Oral Lung Cancer Drug
Nuvation Bio’s first approved product is Ibtrozi, a CNS-active ROS1 inhibitor that in pivotal studies showed high rates of treatment response in patients with non-small cell lung cancer.
June 12, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Nuvation Bio and Eisai Enter into Exclusive Licensing Agreement for Taletrectinib in Europe and Additional Countries Outside U.S., China and Japan
January 12, 2026
·
13 min read
Press Releases
Nuvation Bio to Participate in Upcoming Investor Conferences - October 30, 2025
October 31, 2025
·
1 min read
Press Releases
Nuvation Bio Reports Third Quarter 2025 Financial Results and Provides Business Update
November 3, 2025
·
19 min read
Press Releases
Nuvation Bio Reports Preliminary Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Outlook Ahead of 44th Annual J.P. Morgan Healthcare Conference
January 12, 2026
·
14 min read
Press Releases
Nuvation Bio to Participate in Upcoming September 2025 Investor Conferences
August 28, 2025
·
1 min read
Press Releases
Nuvation Bio Announces Publication of Positive Phase 2 Study Results for Safusidenib for the Treatment of Grade 2 IDH1-Mutant Glioma in Neuro-Oncology
December 3, 2025
·
7 min read
Press Releases
Nuvation Bio to Report Third Quarter 2025 Financial Results and Provide Business Update on November 3, 2025
October 20, 2025
·
1 min read
1 of 27
Next
